| 2020-11-24 |
1 |
Complaint |
Book listed patent for Myrbetriq®
Tablets, United States Patent No. 6,346,532 (“the ’532 Patent”) against… action for patent infringement of United States Patent No. 10,842,780
(“the ’780 Patent”), arising under…7,342,117 (“the ’117 Patent”), 7,982,049 (“the ’049 Patent”),
8,835,474 (“the ’474 Patent”) and RE44,872 (“the…the then-listed patents in the Orange Book for Myrbetriq®
Tablets, United States Patent Nos. 7,342,117…
the ’780 Patent because, inter alia, they concluded before the issuance of the ’780 Patent.
|
External link to document |
| 2023-02-21 |
523 |
Redacted Document |
accompanying Paragraph IV certification for U.S. Patent Nos. 7,342,117; 7,982,049;
…accompanying Paragraph IV certification for U.S. Patent Nos. 7,342,117, 7,982,049, 8,835,474,
and RE44,872 …,
journal, patent, patent publication, certified file history of a patent or patent application, or… infringement of United States Patent No. 10,842,780 (“the ’780 Patent”) based
on Sandoz’s September…infringement of United States Patent No. 10,842,780 (“the ’780
Patent”) based on Sandoz’s September |
External link to document |
| 2023-06-09 |
571 |
Order - Memorandum and Order |
having been long known, e.g., U.S. Pat. No. 6,346,532; Astellas Pharma Inc. v. Actavis
Elizabeth …MEMORANDUM AND ORDER, claims 5, 20, and 25 of U.S. Patent No. 10,842,780 are invalid. All pending motions…matter is before the Court for final decision on patent-infringement charges
arising under the Hatch-Waxman…the heels of a previous suit involving different patents but the same Abbreviated
New Drug Applications…contrasted by its inefficacy on a full one—U.S. Patent No. 10,842,780
claims the extended-release formulation |
External link to document |
| 2021-03-16 |
78 |
Counterclaim AND Answer to Complaint |
Book listed patent for Myrbetriq® Tablets, United States
Patent No. 6,346,532 (“the ‘532 Patent”) against…“Notification of Certification for U.S. Patent Nos. 6,346,532; 6,562,375; 7,342,117;
7,982,049; 8,835,474…Letter”) to the 6,346,532, 6,562,375, 7,342,117, 7,982,049, 8,835,474,
and RE44,872 patent holder and the… action for patent infringement of United States Patent No. 10,842,780
(“the ‘780 Patent”), arising under…infringement of U.S. Patent No. 10,842,780 (“the 780 Patent”) arising under the
United States patent laws and Title |
External link to document |
